Shares of Repros Therapeutics (RPRX) rocket up 13% in AH trading after the firm announces data from a recent study showed a does of its Androxal treatment displays similar efficacy to similar FDA-approved testosterone-boosting gels.
Technical side stock has some resistance level $5.23, $5.75 & $6.47 but so far no volume this stock .I willkeep on eye for today's trading.
Technical side stock has some resistance level $5.23, $5.75 & $6.47 but so far no volume this stock .I willkeep on eye for today's trading.
More Stocks News
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com/